These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2963586)

  • 21. Population pharmacokinetics of teicoplanin in hospitalized elderly patients using cystatin C as an indicator of renal function.
    Kasai H; Tsuji Y; Hiraki Y; Tsuruyama M; To H; Yamamoto Y
    J Infect Chemother; 2018 Apr; 24(4):284-291. PubMed ID: 29292178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of a modified bioassay for monitoring serum teicoplanin and vancomycin in febrile neutropenic patients.
    Kureishi A; Jewesson PJ; Bartlett KH; Cole CD; Chow AW
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1642-7. PubMed ID: 2149492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Teicoplanin physiologically based pharmacokinetic modeling offers a quantitative assessment of a theoretical influence of serum albumin and renal function on its disposition.
    Emoto C; Johnson TN; Yamada T; Yamazaki H; Fukuda T
    Eur J Clin Pharmacol; 2021 Aug; 77(8):1157-1168. PubMed ID: 33527208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Albumin concentration significantly impacts on free teicoplanin plasma concentrations in non-critically ill patients with chronic bone sepsis.
    Brink AJ; Richards GA; Lautenbach EE; Rapeport N; Schillack V; van Niekerk L; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2015 Jun; 45(6):647-51. PubMed ID: 25819167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Teicoplanin pharmacokinetics in intravenous drug abusers being treated for bacterial endocarditis.
    Rybak MJ; Lerner SA; Levine DP; Albrecht LM; McNeil PL; Thompson GA; Kenny MT; Yuh L
    Antimicrob Agents Chemother; 1991 Apr; 35(4):696-700. PubMed ID: 1829880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of teicoplanin in man after intravenous administration.
    Traina GL; Bonati M
    J Pharmacokinet Biopharm; 1984 Apr; 12(2):119-28. PubMed ID: 6238156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function.
    Aweeka F; Jayesekara D; Horton M; Swan S; Lambrecht L; Wilner KD; Sherwood J; Anziano RJ; Smolarek TA; Turncliff RZ
    Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):27S-33S. PubMed ID: 10771451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of intraperitoneal teicoplanin in patients with chronic renal failure on continuous ambulatory peritoneal dialysis.
    Bonati M; Traina GL; Gentile MG; Fellin G; Rosina R; Cavenaghi L; Buniva G
    Br J Clin Pharmacol; 1988 Jun; 25(6):761-5. PubMed ID: 2974299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population pharmacokinetics of teicoplanin administered by subcutaneous or intravenous route and simulation of optimal loading dose regimen.
    Cazaubon Y; Venisse N; Mimoz O; Maire P; Ducher M; Bourguignon L; Goutelle S
    J Antimicrob Chemother; 2017 Oct; 72(10):2804-2812. PubMed ID: 29091222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of teicoplanin in patients undergoing chronic haemodialysis.
    Papaioannou MG; Marinaki S; Pappas M; Stamatiadis D; Giamarellos-Bourboulis EJ; Giamarellou H; Stathakis C
    Int J Antimicrob Agents; 2002 Mar; 19(3):233-6. PubMed ID: 11932147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of individual components of teicoplanin in man.
    Bernareggi A; Danese A; Cometti A; Buniva G; Rowland M
    J Pharmacokinet Biopharm; 1990 Dec; 18(6):525-43. PubMed ID: 2149149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Teicoplanin pharmacokinetics in critically ill patients on continuous veno-venous hemofiltration.
    Bellmann R; Falkensammer G; Seger C; Weiler S; Kountchev J; Joannidis M
    Int J Clin Pharmacol Ther; 2010 Apr; 48(4):243-9. PubMed ID: 20353745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Applicability of teicoplanin dosage adjustment guidelines for renally impaired patients over the range of 3 to 30 mg kg-1.
    Smithers JA; Thompson GA; Kenny MT; Dulworth JK; Kulmala HK; Lewis EW; Ruberg SJ; Shapiro BE; Keane WF; Halstenson CE
    Biopharm Drug Dispos; 1992 Nov; 13(8):571-81. PubMed ID: 1421051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Teicoplanin pharmacokinetics and bioavailability during peritoneal dialysis.
    Brouard RJ; Kapusnik JE; Gambertoglio JG; Schoenfeld PY; Sachdeva M; Freel K; Tozer TN
    Clin Pharmacol Ther; 1989 Jun; 45(6):674-81. PubMed ID: 2525081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of teicoplanin during cardiopulmonary bypass surgery.
    Mini E; Mazzei T; Reali EF; Novelli A; Periti P
    Int J Clin Pharmacol Res; 1989; 9(4):287-92. PubMed ID: 2528510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Teicoplanin pharmacokinetics in healthy volunteers after administration of intravenous loading and maintenance doses.
    Outman WR; Nightingale CH; Sweeney KR; Quintiliani R
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2114-7. PubMed ID: 2149920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of single- and multiple-dose teicoplanin in healthy volunteers.
    Carver PL; Nightingale CH; Quintiliani R; Sweeney K; Stevens RC; Maderazo E
    Antimicrob Agents Chemother; 1989 Jan; 33(1):82-6. PubMed ID: 2523689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of teicoplanin in children.
    Tarral E; Jehl F; Tarral A; Simeoni U; Monteil H; Willard D; Geisert J
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():47-51. PubMed ID: 2965131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity and human pharmacokinetics of teicoplanin.
    Verbist L; Tjandramaga B; Hendrickx B; Van Hecken A; Van Melle P; Verbesselt R; Verhaegen J; De Schepper PJ
    Antimicrob Agents Chemother; 1984 Dec; 26(6):881-6. PubMed ID: 6240962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Influence of arteriovenous hemofiltration on teicoplanin pharmacokinetics].
    Choufane S; Lobjoie E; Tinturier F
    Ann Fr Anesth Reanim; 1996; 15(8):1168-72. PubMed ID: 9636789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.